Male genital disease, specifically lichen sclerosus and its progression to penile cancer, requires a shift in clinical perspective. Lichen sclerosus is a clinical diagnosis caused by chronic exposure to urine in uncircumcised men rather than an autoimmune process. Management involves ultra-potent topical steroids and barrier protection, with circumcision reserved for cases resistant to medical therapy to mitigate the significant risk of squamous cell carcinoma. Penile cancer represents a skin-based pathology, distinct from urological conditions, with pathways involving both HPV and chronic inflammatory states like lichen sclerosus. Evidence suggests that post-exposure HPV vaccination may reduce recurrence rates in patients with HPV-related lesions. Dr. Christopher Bunker, a specialist from University College London, emphasizes that clinicians must actively screen for these conditions, as early diagnosis and definitive treatment are essential for preventing long-term morbidity in aging male populations.
Sign in to continue reading, translating and more.
Open full episode in Podwise
